Parmax Pharma
Parmax Pharma Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Parmax Pharma
Start SIPParmax Pharma Investment Rating
-
Master Rating:
-
Parmax Pharma has an operating revenue of Rs. 16.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company has a debt to equity of 76%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 5 | 2 | 2 | 7 |
| Operating Expenses Qtr Cr | 3 | 2 | 2 | 6 |
| Operating Profit Qtr Cr | 2 | 0 | -1 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 2 | -1 | -1 | 0 |
Parmax Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 32.2
- 50 Day
- 33.82
- 100 Day
- 34.88
- 200 Day
- 36.23
- 20 Day
- 32.25
- 50 Day
- 34.16
- 100 Day
- 35.81
- 200 Day
- 34.65
Parmax Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 30.54 |
| Second Resistance | 30.57 |
| Third Resistance | 30.58 |
| RSI | 37.18 |
| MFI | 8.97 |
| MACD Single Line | -0.9 |
| MACD | -1.06 |
| Support | |
|---|---|
| First Resistance | 30.5 |
| Second Resistance | 30.49 |
| Third Resistance | 30.46 |
Parmax Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 805 | 80,500 | 100 |
| Week | 396 | 37,149 | 93.93 |
| 1 Month | 661 | 50,432 | 76.26 |
| 6 Month | 2,511 | 196,140 | 78.12 |
Parmax Pharma Result Highlights
Parmax Pharma Synopsis
BSE-Medical-Diversified
Parmax Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 18.25 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2022. Parmax Pharma Ltd. is a Public Limited Listed company incorporated on 02/11/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1994PLC023504 and registration number is 023504.| Market Cap | 11 |
| Sales | 16 |
| Shares in Float | 0.26 |
| No of funds | |
| Yield |
| Book Value | 2.17 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 76 |
| Alpha | -0.04 |
| Beta | 0.14 |
Parmax Pharma
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 30.8% | 30.8% | 30.8% | |
| Individual Investors | 65.36% | 65.37% | 68% | |
| Others | 3.84% | 3.83% | 1.2% |
Parmax Pharma Management
| Name | Designation |
|---|---|
| Mr. Umang Alkesh Gosalia | Managing Director |
| Mr. Pramay A Chhatra | Independent Director |
| Ms. Ami R Shah | Independent Director |
Parmax Pharma Forecast
Price Estimates
Parmax Pharma FAQs
What is Share Price of Parmax Pharma ?
Parmax Pharma share price is ₹29 As on 28 March, 2023 | 08:31
What is the Market Cap of Parmax Pharma ?
The Market Cap of Parmax Pharma is ₹10.8 Cr As on 28 March, 2023 | 08:31
What is the P/E ratio of Parmax Pharma ?
The P/E ratio of Parmax Pharma is -33.6 As on 28 March, 2023 | 08:31
What is the PB ratio of Parmax Pharma ?
The PB ratio of Parmax Pharma is 1.6 As on 28 March, 2023 | 08:31